Oakworth Capital Inc. Takes Position in Amdocs Limited (NASDAQ:DOX)

Oakworth Capital Inc. bought a new position in Amdocs Limited (NASDAQ:DOXFree Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 300 shares of the technology company’s stock, valued at approximately $26,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Cookson Peirce & Co. Inc. raised its stake in shares of Amdocs by 9.8% in the fourth quarter. Cookson Peirce & Co. Inc. now owns 5,241 shares of the technology company’s stock valued at $461,000 after acquiring an additional 468 shares during the period. Mackenzie Financial Corp grew its position in Amdocs by 32.4% in the 4th quarter. Mackenzie Financial Corp now owns 71,351 shares of the technology company’s stock valued at $6,271,000 after acquiring an additional 17,447 shares during the last quarter. Lecap Asset Management Ltd. bought a new stake in Amdocs during the 4th quarter valued at about $264,000. Vaughan David Investments LLC IL raised its position in Amdocs by 1.7% during the 4th quarter. Vaughan David Investments LLC IL now owns 376,817 shares of the technology company’s stock valued at $33,118,000 after purchasing an additional 6,448 shares in the last quarter. Finally, Signature Estate & Investment Advisors LLC lifted its holdings in shares of Amdocs by 5.7% in the 4th quarter. Signature Estate & Investment Advisors LLC now owns 30,040 shares of the technology company’s stock worth $2,640,000 after buying an additional 1,610 shares during the period. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. StockNews.com lowered Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Friday, March 15th. Barclays upped their price target on shares of Amdocs from $105.00 to $115.00 and gave the stock an “overweight” rating in a research report on Thursday, February 8th. Finally, Citigroup increased their price objective on shares of Amdocs from $96.00 to $104.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Amdocs presently has an average rating of “Buy” and an average price target of $108.60.

Get Our Latest Analysis on DOX

Amdocs Trading Up 0.2 %

NASDAQ DOX opened at $85.11 on Friday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.21. The firm has a market cap of $10.00 billion, a PE ratio of 18.22, a price-to-earnings-growth ratio of 1.38 and a beta of 0.69. Amdocs Limited has a 52 week low of $78.38 and a 52 week high of $99.75. The company has a 50 day moving average price of $90.10 and a 200 day moving average price of $87.23.

Amdocs (NASDAQ:DOXGet Free Report) last released its quarterly earnings results on Tuesday, February 6th. The technology company reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.16. Amdocs had a return on equity of 17.79% and a net margin of 11.30%. The company had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.24 billion. During the same period last year, the business posted $1.33 earnings per share. The firm’s revenue was up 5.0% compared to the same quarter last year. As a group, sell-side analysts forecast that Amdocs Limited will post 5.87 EPS for the current fiscal year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be issued a $0.479 dividend. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.25%. This is a boost from Amdocs’s previous quarterly dividend of $0.44. Amdocs’s dividend payout ratio (DPR) is currently 41.11%.

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Recommended Stories

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.